SUBJECTS : Drug Discovery | Drug Delivery | Medicinal Chemistry | | Translational Science | Cell Therap
Medicine in Drug Discovery: 2021, vol: , issue:
- 1)- Marcin Delijewski, Jacek Haneczok. AI drug discovery screening for COVID-19 reveals zafirlukast as a repurposing candidate. Medicine in drug discovery. 2021, 9: 100077
Cited : 30Read More - 2)- Gregory Upert, Anatol Luther, Daniel Obrecht, Philipp Ermert. Emerging peptide antibiotics with therapeutic potential. Medicine in drug discovery. 2021, 9: 100078Cited : 57Read More
- 3)- Tahereh Seifi, Ali Reza Kamali. Antiviral performance of graphene-based materials with emphasis on COVID-19: A review. Medicine in drug discovery. 2021, 11: 100099Cited : 51Read More
- 4)- Subham Das, Anu Kunnath Ramachandran, Sumit Raosaheb Birangal, Saleem Akbar, Bahar Ahmed, Alex Joseph. The controversial therapeutic journey of chloroquine and hydroxychloroquine in the battle against SARS-CoV-2: A comprehensive review. Medicine in drug discovery. 2021, 10: 100085Cited : 17Read More
- 5)- Fedaa Ali, Amal Kasry, Muhamed Amin. The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutant. Medicine in drug discovery. 2021, 10: 100086Cited : 153Read More
- 6)- Nikky Goel, Razi Ahmad, Huma Fatima, Sunil Kumar Khare. New threatening of SARS-CoV-2 coinfection and strategies to fight the current pandemic. Medicine in drug discovery. 2021, 10: 100089Cited : 13Read More
- 7)- Xu Li, Jinchao Yu, Zhiming Zhang, Jing Ren, Alex E Peluffo, Wen Zhang, Yujie Zhao, Jiawei Wu, Kaijing Yan, Daniel Cohen, Wenjia Wang. Network bioinformatics analysis provides insight into drug repurposing for COVID-19. Medicine in drug discovery. 2021, 10: 100090Cited : 45Read More
- 8)- Shaimaa S Goher, Fedaa Ali, Muhamed Amin. The Delta Variant Mutations in the Receptor Binding Domain of SARS-CoV-2 Show Enhanced Electrostatic Interactions with the ACE2. Medicine in drug discovery. 2021, : 100114Cited : 29Read More
